Cowen Inc’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Cowen Inc’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$144K	Buy	+6,000	New	+$152K	0.01%	275
2018 Q1	–	Sell	-53,500	Closed	-$781K	–	334
2017 Q4	$781K	Buy	+53,500	New	+$751K	﹤0.01%	163
2017 Q3	–	Sell	-164,400	Closed	-$1.2M	–	361
2017 Q2	$1.2M	Buy	+164,400	New	+$2.04M	0.06%	155
2016 Q1	–	Sell	-54,500	Closed	-$1.18M	–	379
2015 Q4	$1.18M	Sell	54,500 -83,695	-61%	-$1.63M	0.09%	143
2015 Q3	$2.74M	Sell	138,195 -5,404	-4%	-$171K	0.16%	101
2015 Q2	$4.99M	Buy	143,599 +42,899	+43%	+$1.31M	0.3%	83
2015 Q1	$2.62M	Sell	100,700 -289,366	-74%	-$5.3M	0.22%	74
2014 Q4	$5.02M	Buy	390,066 +36,400	+10%	+$456K	0.4%	72
2014 Q3	$4.34M	Buy	353,666 +267,866	+312%	+$3.11M	0.45%	58
2014 Q2	$1.36M	Buy	85,800 +53,500	+166%	+$764K	0.15%	127
2014 Q1	$488K	Buy	+32,300	New	+$365K	0.06%	138

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Cowen Inc's HZNP Position: Q2 2019 in Review

Cowen Inc opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2019: 6,000 shares worth $144K. The stake represents 0.01% of the portfolio and ranks #275 among its holdings. This is a return to the name: Cowen Inc previously reported a position in HZNP as recently as Q4 2017.

Cowen Inc first reported a position in HZNP in Q1 2014 and has held it in 11 quarters since. The position peaked at $5.02M in Q4 2014. 272 funds tracked by Wall St. Rank hold HZNP as of Q2 2019.

Cowen Inc held 6,000 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $144K as of Q2 2019.
Horizon Therapeutics Public Limited Company Ordinary Shares was a new Cowen Inc position in Q2 2019.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.01% of Cowen Inc's portfolio in Q2 2019, its #275 holding.
Cowen Inc first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and has held it in 11 quarters since.
Cowen Inc's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $5.02M in Q4 2014.
272 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.